Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: AMERICAN COLLEGE OF MEDICAL TOXICOLOGY, INC.
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2023-09-25 to 2026-09-29
Current total value of award: $2710011
Description: CHARACTERIZE NALOXONES CLINICAL USE, RISKS, BENEFITS, AND EFFECTIVENESS FOR REVERSING OPIOID OVERDOSES IN PRE-HOSPITAL SETTINGS.  USING QUALITATIVE AND QUANTITATIVE BLOOD TOXICOLOGY TESTS, DETERMINE THE RISKS, BENEFITS, EFFECTIVENESS OF HIGH DOSE NAL